Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.
about
Microbial biofilms: from ecology to molecular geneticsAlternative strategies for proof-of-principle studies of antibacterial agentsPseudomonas aeruginosa biofilms in cystic fibrosisAnalysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress responseMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaAdvances in microbial biofilm prevention on indwelling medical devices with emphasis on usage of acoustic energyEnhancement of vancomycin activity against biofilms by using ultrasound-targeted microbubble destruction.Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coliUltrasonic enhancement of antibiotic action on gram-negative bacteria.A continuous culture biofilm model of cariogenic responses.Oral bacteria in multi-species biofilms can be killed by red light in the presence of toluidine blue.Decontamination of rough titanium surfaces with diode lasers: microbiological findings on in vivo grown biofilms.In situ identification of streptococci and other bacteria in initial dental biofilm by confocal laser scanning microscopy and fluorescence in situ hybridization.Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability.Ecological considerations in the treatment of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis periodontal infections.Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complexThe role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology.Bacterial adhesion: seen any good biofilms lately?Stability and change in estuarine biofilm bacterial community diversity.Bacterial biofilms and the bioelectric effect.The Escherichia coli sigma(E)-dependent extracytoplasmic stress response is controlled by the regulated proteolysis of an anti-sigma factor.Periodontitis as an infectious disease: specific features and their implications.Microbial shifts after subgingival debridement and formation of bacterial resistance when combined with local or systemic antimicrobials.Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa.Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin.Topical and systemic antibiotics in the management of periodontal diseases.Antimicrobial Tolerance in Biofilms.Effects of nonsurgical periodontal therapy on the microbiota.Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor.Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy.Should Antibiotics Be Prescribed to Treat Chronic Periodontitis?In Vitro Efficacy of Nonantibiotic Treatments on Biofilm Disruption of Gram-Negative Pathogens and an In Vivo Model of Infectious Endometritis Utilizing Isolates from the Equine Uterus.Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression.Biofilms in ear, nose, and throat infections: how important are they?Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus.Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner.Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases.Evolving concepts in biofilm infections.Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans
P2860
Q21999032-2A6D8234-90D6-4AE4-BCED-BFAC9DC5C0F0Q26850895-89414E92-B5D8-4FC4-9BAB-F56935CDBB95Q28299966-B851490D-41DF-4768-8348-52731D4EEF12Q28492822-EECA4375-C995-41B5-A87D-91264D96C6F0Q29615286-E7004A6A-2FF0-4950-9371-68B99D78B048Q30467753-16A9ECCA-EA17-4DC9-BBE3-FE2DFEF4505CQ30467947-3324AA51-37B1-484A-8676-798B91F888B0Q30501322-5C7728C2-702B-42CB-AC91-9FA5F7A7A2ECQ30502710-CF99C8C3-B8D6-4215-9F23-5BEE15AE70C2Q30985844-D1CC84AF-0543-45FD-A9E8-FF9B69ECAF40Q33184275-F1DE0955-0B56-47A0-9CF1-A0C71B603707Q33269260-F8C98602-1FEA-4C79-9733-67D7E87A2832Q33306576-01EC03C2-1EE1-4E5B-8013-3285F8771A88Q33718373-4204A61E-A9A0-4019-8B9F-282FC7F680F1Q33752065-BE31FB51-3184-441A-8CFC-39BC492594B2Q33979968-DD54AD2D-385F-4AD1-9D00-70FE15631F21Q34436534-DB654371-56EC-49C5-9EE3-F710CAA3DF6EQ34507418-EDCB6A84-01C8-4CB8-B18A-400BC91C6CF6Q34587156-46E717FC-2DD0-4648-B485-70432216CB5BQ35023563-88C6E6D2-5C3B-4B64-B2E6-8E1B2A6D18EFQ35126515-4F0C8C7C-F7AB-49E8-AEF1-6CC100408E50Q35206083-081A437C-683B-44CD-8BE5-4246D6B1B00FQ35219134-4078A680-7256-4A6F-8CEA-6770EF13A728Q35219149-16C380EB-54B8-43C7-A0FA-41CA7EE97499Q35587312-66F1FC87-C83F-494D-995C-7A5296EEED7AQ35660517-2165DBF0-B018-447C-B6A3-BAA8D4609235Q35684280-4F97E067-B92F-47E4-9CA0-48043D3A7E97Q35865912-260D4345-A07F-41F0-825F-63F0F85054E5Q35872099-36EB37D9-68E1-4FEE-8390-2345F5D14DFBQ35908864-BAA4EC3B-2D32-4049-8441-42A8F1373A92Q36108136-0B82A058-83A2-4C00-A4FD-6612135F3F04Q36118234-8FD43C4A-B21A-4788-A121-142BD400FDD3Q36620962-5CBBF3E2-4E21-47C6-A40D-FFCDB4CAE166Q36709346-01E60FBA-C49E-4507-888D-BC94266D5D2BQ36784198-F52F5E9A-FF81-4CB0-B872-066F7487369FQ37116078-88A6D19A-D4D6-4A46-B2CD-FDB77515F0E6Q37191480-F2731E9D-4D56-4911-831B-A4733E8A243BQ37313294-11042B03-91B8-44AC-ADA2-58B2CB96D64FQ37449114-7A192772-3EC4-4D75-BB8A-F73C01D1FE15Q37473280-6B30DA39-93C7-42E6-A70B-6DF4DDCB3FD4
P2860
Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@ast
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@en
type
label
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@ast
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@en
prefLabel
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@ast
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@en
P2093
P2860
P356
P1476
Establishment of aging biofilm ...... ance to antimicrobial therapy.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.7.1347
P407
P577
1992-07-01T00:00:00Z